Evaluating Treatment Options for Peripheral Artery Disease
mrr5831
Telmisartan, an angiotensin receptor blocker drug, did not improve walking performance in patients with lower extremity peripheral artery disease, according to a recent clinical trial published in JAMA. The post Evaluating Treatment Options for Peripheral Artery Disease appeared first on News Center .